Lucile Benhaim

Learn More
4121 Background: Advanced gastric cancer (AGC) remains the second leading cause of cancer death worldwide. We performed a phase II study to evaluate cetuximab combined with XELOX as first-line(More)
3542 Background: Postoperative chemoradiation (CRT) for locally advanced rectal cancers has improved overall survival (OS) and pelvic control. The SWOG S9304 (INT 0144) trial was designed to(More)